Clinical Trial Update: Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma [NA]

View source ↗

Summary

This ClinicalTrials.gov entry describes a trial evaluating intratumoral targeted hyperthermia therapy (THT) for stage 3C/3D/4M1 cutaneous metastatic melanoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Sona Nanotech Inc | Conditions: Cutaneous Metastatic Melanoma | NA | Status: NOT_YET_RECRUITING